{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:43:47Z","timestamp":1786149827697,"version":"build-2736575974"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NSFC Seed Funding Project of Xi\u2019an Honghui Hospital","award":["2025zz-qn07"],"award-info":[{"award-number":["2025zz-qn07"]}]},{"name":"Research Project of Xi'an Municipal Health Commission","award":["2026qn08"],"award-info":[{"award-number":["2026qn08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08419-0","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:56:15Z","timestamp":1781520975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PPAR\u03b3 signalling pathway: molecular mechanisms and therapeutic potential in ligamentum flavum hypertrophy and lumbar spinal stenosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Xue","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuanjiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"8419_CR1","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.2147\/DDDT.S274812","volume":"14","author":"H Wang","year":"2020","unstructured":"Wang H, Jiang Z, Pang Z, Zhou T, Gu Y. Acacetin Alleviates Inflammation and Matrix Degradation in Nucleus Pulposus Cells and Ameliorates Intervertebral Disc Degeneration in vivo. Drug Des Devel Ther. 2020;14:4801\u201313.","journal-title":"Drug Des Devel Ther"},{"issue":"8","key":"8419_CR2","doi-asserted-by":"publisher","first-page":"9854","DOI":"10.1096\/fj.202000635R","volume":"34","author":"C Sun","year":"2020","unstructured":"Sun C, Zhang H, Wang X, Liu X. Ligamentum flavum fibrosis and hypertrophy: Molecular pathways, cellular mechanisms, and future directions. Faseb J. 2020;34(8):9854\u201368.","journal-title":"Faseb J"},{"issue":"8","key":"8419_CR3","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/00007632-199404150-00009","volume":"19","author":"F Postacchini","year":"1994","unstructured":"Postacchini F, Gumina S, Cinotti G, Perugia D, Demartino C. Ligamenta flava in lumbar disc herniation and spinal stenosis. Light and electron microscopic morphology. Spine (Phila Pa 1976). 1994;19(8):917\u201322.","journal-title":"Spine (Phila Pa 1976)"},{"key":"8419_CR4","doi-asserted-by":"publisher","first-page":"861567","DOI":"10.3389\/fendo.2022.861567","volume":"13","author":"B Zhang","year":"2022","unstructured":"Zhang B, Yuan L, Chen G, Chen X, Yang X, Fan T, Sun C, Fan D, Chen Z. Deciphering Obesity-Related Gene Clusters Unearths SOCS3 Immune Infiltrates and 5mC\/m6A Modifiers in Ossification of Ligamentum Flavum Pathogenesis. Front Endocrinol (Lausanne). 2022;13:861567.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"8419_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s12276-023-01023-y","volume":"55","author":"S Wang","year":"2023","unstructured":"Wang S, Qu Y, Fang X, Ding Q, Zhao H, Yu X, Xu T, Lu R, Jing S, Liu C, et al. Decorin: a potential therapeutic candidate for ligamentum flavum hypertrophy by antagonizing TGF-beta1. Exp Mol Med. 2023;55(7):1413\u201323.","journal-title":"Exp Mol Med"},{"issue":"3","key":"8419_CR6","doi-asserted-by":"publisher","first-page":"e1260","DOI":"10.1002\/jsp2.1260","volume":"6","author":"KG Burt","year":"2023","unstructured":"Burt KG, Viola DC, Lisiewski LE, Lombardi JM, Amorosa LF, Chahine NO. An in vivo model of ligamentum flavum hypertrophy from early-stage inflammation to fibrosis. JOR Spine. 2023;6(3):e1260.","journal-title":"JOR Spine"},{"issue":"6","key":"8419_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.31616\/asj.2020.0041","volume":"14","author":"D Hulmani","year":"2020","unstructured":"Hulmani D, Garg B, Mehta N, Mridha AR, Nag TC, Farooque K. Morphological Changes in the Ligamentum Flavum in Degenerative Lumbar Canal Stenosis: A Prospective, Comparative Study. Asian Spine J. 2020;14(6):773\u201381.","journal-title":"Asian Spine J"},{"issue":"1","key":"8419_CR8","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1097\/BSD.0b013e3182698501","volume":"26","author":"JO Park","year":"2013","unstructured":"Park JO, Lee BH, Kang YM, Kim TH, Yoon JY, Kim H, Kwon UH, Lee KI, Lee HM, Moon SH. Inflammatory cytokines induce fibrosis and ossification of human ligamentum flavum cells. J Spinal Disord Tech. 2013;26(1):E6\u201312.","journal-title":"J Spinal Disord Tech"},{"issue":"23","key":"8419_CR9","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1097\/01.brs.0000188117.77657.ee","volume":"30","author":"K Sairyo","year":"2005","unstructured":"Sairyo K, Biyani A, Goel V, Leaman D, Booth RJ, Thomas J, Gehling D, Vishnubhotla L, Long R, Ebraheim N. Pathomechanism of ligamentum flavum hypertrophy: a multidisciplinary investigation based on clinical, biomechanical, histologic, and biologic assessments. Spine (Phila Pa 1976). 2005;30(23):2649\u201356.","journal-title":"Spine (Phila Pa 1976)"},{"key":"8419_CR10","doi-asserted-by":"crossref","unstructured":"Kokeny G, Calvier L, Hansmann G. PPARgamma and TGFbeta-major regulators of metabolism, inflammation, and fibrosis in the lungs and kidneys. Int J Mol Sci. 2021;22(19).","DOI":"10.3390\/ijms221910431"},{"issue":"1","key":"8419_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","volume":"9","author":"C Janani","year":"2015","unstructured":"Janani C, Ranjitha KB. PPAR gamma gene\u2013a review. Diabetes Metab Syndr. 2015;9(1):46\u201350.","journal-title":"Diabetes Metab Syndr"},{"issue":"10","key":"8419_CR12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1161\/CIRCULATIONAHA.106.663120","volume":"115","author":"G Hansmann","year":"2007","unstructured":"Hansmann G, Wagner RA, Schellong S, Perez VA, Urashima T, Wang L, Sheikh AY, Suen RS, Stewart DJ, Rabinovitch M. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation. 2007;115(10):1275\u201384.","journal-title":"Circulation"},{"issue":"6","key":"8419_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ctrv.2004.04.004","volume":"30","author":"S Theocharis","year":"2004","unstructured":"Theocharis S, Margeli A, Vielh P, Kouraklis G. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators. Cancer Treat Rev. 2004;30(6):545\u201354.","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"8419_CR14","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1517\/13543784.16.10.1561","volume":"16","author":"C Giaginis","year":"2007","unstructured":"Giaginis C, Margeli A, Theocharis S. Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis. Expert Opin Investig Drugs. 2007;16(10):1561\u201372.","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"8419_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.phrs.2009.02.005","volume":"60","author":"C Giaginis","year":"2009","unstructured":"Giaginis C, Giagini A, Theocharis S. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands as potential therapeutic agents to treat arthritis. Pharmacol Res. 2009;60(3):160\u20139.","journal-title":"Pharmacol Res"},{"key":"8419_CR16","doi-asserted-by":"publisher","first-page":"1117416","DOI":"10.3389\/fgene.2023.1117416","volume":"14","author":"Y Gu","year":"2023","unstructured":"Gu Y, Yu W, Qi M, Hu J, Jin Q, Wang X, Wang C, Chen Y, Yuan W. Identification and validation of hub genes and pathways associated with mitochondrial dysfunction in hypertrophy of ligamentum flavum. Front Genet. 2023;14:1117416.","journal-title":"Front Genet"},{"issue":"1","key":"8419_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13062-023-00436-z","volume":"18","author":"Y Cao","year":"2023","unstructured":"Cao Y, Li J, Qiu S, Ni S, Duan Y. ACSM5 inhibits ligamentum flavum hypertrophy by regulating lipid accumulation mediated by FABP4\/PPAR signaling pathway. Biol Direct. 2023;18(1):75.","journal-title":"Biol Direct"},{"key":"8419_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.matbio.2018.01.019","volume":"68\u201369","author":"P Pakshir","year":"2018","unstructured":"Pakshir P, Hinz B. The big five in fibrosis: Macrophages, myofibroblasts, matrix, mechanics, and miscommunication. Matrix Biol. 2018;68\u201369:81\u201393.","journal-title":"Matrix Biol"},{"key":"8419_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mam.2018.06.003","volume":"65","author":"R Weiskirchen","year":"2019","unstructured":"Weiskirchen R, Weiskirchen S, Tacke F. Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications. Mol Aspects Med. 2019;65:2\u201315.","journal-title":"Mol Aspects Med"},{"issue":"2","key":"8419_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3892\/ijmm.2016.2631","volume":"38","author":"YL Cao","year":"2016","unstructured":"Cao YL, Duan Y, Zhu LX, Zhan YN, Min SX, Jin AM. TGF-beta1, in association with the increased expression of connective tissue growth factor, induce the hypertrophy of the ligamentum flavum through the p38 MAPK pathway. Int J Mol Med. 2016;38(2):391\u20138.","journal-title":"Int J Mol Med"},{"key":"8419_CR21","doi-asserted-by":"publisher","first-page":"8799240","DOI":"10.1155\/2022\/8799240","volume":"2022","author":"N He","year":"2022","unstructured":"He N, Qi W, Zhao Y, Wang X. Relationship between Severity of Lumbar Spinal Stenosis and Ligamentum Flavum Hypertrophy and Serum Inflammatory Factors. Comput Math Methods Med. 2022;2022:8799240.","journal-title":"Comput Math Methods Med"},{"issue":"3","key":"8419_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/197140091002300316","volume":"23","author":"R Rispoli","year":"2010","unstructured":"Rispoli R, Mastrostefano R, Brunelli F. Morphology and TGF-beta1 Concentration Analysis of Ligamentum Flavum in Patients with Lumbar Canal Stenosis and Lumbar Disc Herniation. Neuroradiol J. 2010;23(3):347\u201353.","journal-title":"Neuroradiol J"},{"issue":"10","key":"8419_CR23","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.7150\/ijms.76077","volume":"19","author":"K Yang","year":"2022","unstructured":"Yang K, Chen Y, Xiang X, Lin Y, Fei C, Chen Z, Lai Z, Yu Y, Tan R, Dong J, et al. EGF Contributes to Hypertrophy of Human Ligamentum Flavum via the TGF-beta1\/Smad3 Signaling Pathway. Int J Med Sci. 2022;19(10):1510\u20138.","journal-title":"Int J Med Sci"},{"issue":"8","key":"8419_CR24","doi-asserted-by":"publisher","first-page":"e13438","DOI":"10.1111\/cpr.13438","volume":"56","author":"ZW Shi","year":"2023","unstructured":"Shi ZW, Zhu L, Song ZR, Liu TJ, Hao DJ. Roles of p38 MAPK signalling in intervertebral disc degeneration. Cell Prolif. 2023;56(8):e13438.","journal-title":"Cell Prolif"},{"issue":"5","key":"8419_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.carpath.2013.01.003","volume":"22","author":"TH Lan","year":"2013","unstructured":"Lan TH, Huang XQ, Tan HM. Vascular fibrosis in atherosclerosis. Cardiovasc Pathol. 2013;22(5):401\u20137.","journal-title":"Cardiovasc Pathol"},{"issue":"25","key":"8419_CR26","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1097\/BRS.0b013e31815b650f","volume":"32","author":"H Kosaka","year":"2007","unstructured":"Kosaka H, Sairyo K, Biyani A, Leaman D, Yeasting R, Higashino K, Sakai T, Katoh S, Sano T, Goel VK, et al. Pathomechanism of loss of elasticity and hypertrophy of lumbar ligamentum flavum in elderly patients with lumbar spinal canal stenosis. Spine (Phila Pa 1976). 2007;32(25):2805\u201311.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"15","key":"8419_CR27","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1097\/01.BRS.0000132510.25378.8C","volume":"29","author":"T Okuda","year":"2004","unstructured":"Okuda T, Baba I, Fujimoto Y, Tanaka N, Sumida T, Manabe H, Hayashi Y, Ochi M. The pathology of ligamentum flavum in degenerative lumbar disease. Spine (Phila Pa 1976). 2004;29(15):1689\u201397.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"3","key":"8419_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1165\/ajrcmb.16.3.9070604","volume":"16","author":"I Ohno","year":"1997","unstructured":"Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M, Isoyama S, Tanno Y, Tamura G, Yamauchi K, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol. 1997;16(3):212\u20139.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"8419_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1165\/ajrcmb.17.5.2562","volume":"17","author":"G Mautino","year":"1997","unstructured":"Mautino G, Oliver N, Chanez P, Bousquet J, Capony F. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol. 1997;17(5):583\u201391.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"8419_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.18632\/aging.101124","volume":"9","author":"B Delire","year":"2016","unstructured":"Delire B, Lebrun V, Selvais C, Henriet P, Bertrand A, Horsmans Y, Leclercq IA. Aging enhances liver fibrotic response in mice through hampering extracellular matrix remodeling. Aging. 2016;9(1):98\u2013113.","journal-title":"Aging"},{"issue":"5","key":"8419_CR31","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1053\/jhep.2003.50196","volume":"37","author":"E Ueberham","year":"2003","unstructured":"Ueberham E, Low R, Ueberham U, Schonig K, Bujard H, Gebhardt R. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology. 2003;37(5):1067\u201378.","journal-title":"Hepatology"},{"issue":"12","key":"8419_CR32","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.2106\/00004623-200512000-00020","volume":"87","author":"JB Park","year":"2005","unstructured":"Park JB, Lee JK, Park SJ, Riew KD. Hypertrophy of ligamentum flavum in lumbar spinal stenosis associated with increased proteinase inhibitor concentration. J Bone Joint Surg Am. 2005;87(12):2750\u20137.","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"8419_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4055\/cios.2009.1.2.81","volume":"1","author":"JB Park","year":"2009","unstructured":"Park JB, Kong CG, Suhl KH, Chang ED, Riew KD. The increased expression of matrix metalloproteinases associated with elastin degradation and fibrosis of the ligamentum flavum in patients with lumbar spinal stenosis. Clin Orthop Surg. 2009;1(2):81\u20139.","journal-title":"Clin Orthop Surg"},{"issue":"7","key":"8419_CR34","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/BSD.0b013e3182495b88","volume":"26","author":"S Lakemeier","year":"2013","unstructured":"Lakemeier S, Schofer MD, Foltz L, Schmid R, Efe T, Rohlfs J, Fuchs-Winkelmann S, El-Zayat BF, Paletta JR, Foelsch C. Expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and matrix metalloproteinases 1, 3, and 9 in hypertrophied ligamentum flavum. J Spinal Disord Tech. 2013;26(7):400\u20136.","journal-title":"J Spinal Disord Tech"},{"issue":"19","key":"8419_CR35","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331(19):1286\u201392.","journal-title":"N Engl J Med"},{"key":"8419_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1146\/annurev.cb.06.110190.003121","volume":"6","author":"J Massague","year":"1990","unstructured":"Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol. 1990;6:597\u2013641.","journal-title":"Annu Rev Cell Biol"},{"issue":"3","key":"8419_CR37","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1172\/JCI114793","volume":"86","author":"M Kulozik","year":"1990","unstructured":"Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T. Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest. 1990;86(3):917\u201322.","journal-title":"J Clin Invest"},{"issue":"6","key":"8419_CR38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00004630-199711000-00002","volume":"18","author":"M Polo","year":"1997","unstructured":"Polo M, Ko F, Busillo F, Cruse CW, Krizek TJ, Robson MC. The 1997 Moyer Award. Cytokine production in patients with hypertrophic burn scars. J Burn Care Rehabil. 1997;18(6):477\u201382.","journal-title":"J Burn Care Rehabil"},{"issue":"3","key":"8419_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/HCO.0000000000000158","volume":"30","author":"NG Frangogiannis","year":"2015","unstructured":"Frangogiannis NG. Inflammation in cardiac injury, repair and regeneration. Curr Opin Cardiol. 2015;30(3):240\u20135.","journal-title":"Curr Opin Cardiol"},{"issue":"11","key":"8419_CR40","doi-asserted-by":"publisher","first-page":"E340","DOI":"10.1097\/01.brs.0000263407.25009.6e","volume":"32","author":"K Sairyo","year":"2007","unstructured":"Sairyo K, Biyani A, Goel VK, Leaman DW, Booth RJ, Thomas J, Ebraheim NA, Cowgill IA, Mohan SE. Lumbar ligamentum flavum hypertrophy is due to accumulation of inflammation-related scar tissue. Spine (Phila Pa 1976). 2007;32(11):E340\u20137.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"3","key":"8419_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jos.2022.01.006","volume":"28","author":"S Nagai","year":"2023","unstructured":"Nagai S, Hachiya K, Takeda H, Ikeda D, Kawabata S, Watanabe K, Kaneko S, Fujita N. Impact of oxidized LDL\/LOX-1 system on ligamentum flavum hypertrophy. J Orthop Sci. 2023;28(3):669\u201376.","journal-title":"J Orthop Sci"},{"issue":"6","key":"8419_CR42","doi-asserted-by":"publisher","first-page":"713","DOI":"10.31616\/asj.2020.0425","volume":"15","author":"K Yagi","year":"2021","unstructured":"Yagi K, Goto Y, Kato K, Suzuki N, Kondo A, Waseda Y, Mizutani J, Kawaguchi Y, Joyo Y, Waguri-Nagaya Y, et al. p38 Mitogen-Activated Protein Kinase Is Involved in Interleukin-6 Secretion from Human Ligamentum Flavum-Derived Cells Stimulated by Tumor Necrosis Factor-alpha. Asian Spine J. 2021;15(6):713\u201320.","journal-title":"Asian Spine J"},{"key":"8419_CR43","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1016\/j.wneu.2020.02.024","volume":"137","author":"E Delen","year":"2020","unstructured":"Delen E, Doganlar O, Delen O, Doganlar ZB, Kilincer C. The Role of JAK-STAT Signaling Activation in Hypertrophied Ligamentum Flavum. World Neurosurg. 2020;137:e506\u201316.","journal-title":"World Neurosurg"},{"issue":"25","key":"8419_CR44","doi-asserted-by":"publisher","first-page":"E1479","DOI":"10.1097\/BRS.0b013e3181f3d2df","volume":"35","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Chen J, Zhong ZM, Yang D, Zhu Q. Is platelet-derived growth factor-BB expression proportional to fibrosis in the hypertrophied lumber ligamentum flavum? Spine (Phila Pa 1976). 2010;35(25):E1479\u201386.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5","key":"8419_CR45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.joca.2005.10.011","volume":"14","author":"MB Schmidt","year":"2006","unstructured":"Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage. 2006;14(5):403\u201312.","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"8419_CR46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/path.853","volume":"194","author":"FB Niessen","year":"2001","unstructured":"Niessen FB, Andriessen MP, Schalkwijk J, Visser L, Timens W. Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars. J Pathol. 2001;194(2):207\u201316.","journal-title":"J Pathol"},{"issue":"3","key":"8419_CR47","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1017\/S0007114509991772","volume":"103","author":"M Sumiyoshi","year":"2010","unstructured":"Sumiyoshi M, Sakanaka M, Kimura Y. Chronic intake of a high-cholesterol diet resulted in hepatic steatosis, focal nodular hyperplasia and fibrosis in non-obese mice. Br J Nutr. 2010;103(3):378\u201385.","journal-title":"Br J Nutr"},{"issue":"2","key":"8419_CR48","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2353\/ajpath.2010.090570","volume":"176","author":"CK Abrass","year":"2010","unstructured":"Abrass CK, Hansen KM, Patton BL. Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor. Am J Pathol. 2010;176(2):839\u201349.","journal-title":"Am J Pathol"},{"issue":"6","key":"8419_CR49","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1083\/jcb.114.6.1285","volume":"114","author":"DM Bradham","year":"1991","unstructured":"Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol. 1991;114(6):1285\u201394.","journal-title":"J Cell Biol"},{"issue":"3","key":"8419_CR50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/1523-1747.ep12363389","volume":"107","author":"K Frazier","year":"1996","unstructured":"Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol. 1996;107(3):404\u201311.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"8419_CR51","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/00002281-200211000-00009","volume":"14","author":"H Ihn","year":"2002","unstructured":"Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol. 2002;14(6):681\u20135.","journal-title":"Curr Opin Rheumatol"},{"key":"8419_CR52","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1749-6632.2000.tb06320.x","volume":"902","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Collen D. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Ann N Y Acad Sci. 2000;902:249\u201362.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"8419_CR53","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1053\/jhep.2002.32524","volume":"35","author":"C Corpechot","year":"2002","unstructured":"Corpechot C, Barbu V, Wendum D, Kinnman N, Rey C, Poupon R, Housset C, Rosmorduc O. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology. 2002;35(5):1010\u201321.","journal-title":"Hepatology"},{"issue":"3","key":"8419_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4254\/wjh.v7.i3.377","volume":"7","author":"GO Elpek","year":"2015","unstructured":"Elpek GO. Angiogenesis and liver fibrosis. World J Hepatol. 2015;7(3):377\u201391.","journal-title":"World J Hepatol"},{"issue":"2","key":"8419_CR55","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/hep.24427","volume":"54","author":"D Thabut","year":"2011","unstructured":"Thabut D, Routray C, Lomberk G, Shergill U, Glaser K, Huebert R, Patel L, Masyuk T, Blechacz B, Vercnocke A, et al. Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology. 2011;54(2):573\u201385.","journal-title":"Hepatology"},{"issue":"14","key":"8419_CR56","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1056\/NEJM199810013391403","volume":"339","author":"M Ristow","year":"1998","unstructured":"Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med. 1998;339(14):953\u20139.","journal-title":"N Engl J Med"},{"issue":"6764","key":"8419_CR57","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/47254","volume":"402","author":"I Barroso","year":"1999","unstructured":"Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature. 1999;402(6764):880\u20133.","journal-title":"Nature"},{"issue":"6","key":"8419_CR58","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.clnu.2006.08.006","volume":"25","author":"AJ Guri","year":"2006","unstructured":"Guri AJ, Hontecillas R, Bassaganya-Riera J. Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition. Clin Nutr. 2006;25(6):871\u201385.","journal-title":"Clin Nutr"},{"issue":"10A","key":"8419_CR59","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1017\/S1368980007000614","volume":"10","author":"G Medina-Gomez","year":"2007","unstructured":"Medina-Gomez G, Gray S, Vidal-Puig A. Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). Public Health Nutr. 2007;10(10A):1132\u20137.","journal-title":"Public Health Nutr"},{"issue":"4","key":"8419_CR60","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1021\/bi048032c","volume":"44","author":"SH Sheu","year":"2005","unstructured":"Sheu SH, Kaya T, Waxman DJ, Vajda S. Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping. Biochemistry-Us. 2005;44(4):1193\u2013209.","journal-title":"Biochemistry-Us"},{"issue":"2","key":"8419_CR61","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.plipres.2005.12.002","volume":"45","author":"JN Feige","year":"2006","unstructured":"Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res. 2006;45(2):120\u201359.","journal-title":"Prog Lipid Res"},{"issue":"12","key":"8419_CR62","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/nm956","volume":"9","author":"AL Hevener","year":"2003","unstructured":"Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM, Olefsky J. Muscle-specific Pparg deletion causes insulin resistance. Nat Med. 2003;9(12):1491\u20137.","journal-title":"Nat Med"},{"issue":"4","key":"8419_CR63","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1371\/journal.pgen.0030064","volume":"3","author":"G Medina-Gomez","year":"2007","unstructured":"Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GS, et al. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. Plos Genet. 2007;3(4):e64.","journal-title":"Plos Genet"},{"issue":"11","key":"8419_CR64","doi-asserted-by":"publisher","first-page":"6712","DOI":"10.1073\/pnas.1031789100","volume":"100","author":"JS Welch","year":"2003","unstructured":"Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci U S A. 2003;100(11):6712\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"8419_CR65","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.041609298","volume":"98","author":"T Claudel","year":"2001","unstructured":"Claudel T, Leibowitz MD, Fievet C, Tailleux A, Wagner B, Repa JJ, Torpier G, Lobaccaro JM, Paterniti JR, Mangelsdorf DJ, et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Acad Sci U S A. 2001;98(5):2610\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"8419_CR66","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.193.7.827","volume":"193","author":"P Desreumaux","year":"2001","unstructured":"Desreumaux P, Dubuquoy L, Nutten S, Peuchmaur M, Englaro W, Schoonjans K, Derijard B, Desvergne B, Wahli W, Chambon P, et al. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)\/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J Exp Med. 2001;193(7):827\u201338.","journal-title":"J Exp Med"},{"issue":"4","key":"8419_CR67","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1172\/JCI7145","volume":"104","author":"CG Su","year":"1999","unstructured":"Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest. 1999;104(4):383\u20139.","journal-title":"J Clin Invest"},{"issue":"5","key":"8419_CR68","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00109-014-1244-0","volume":"93","author":"S Malenfant","year":"2015","unstructured":"Malenfant S, Potus F, Fournier F, Breuils-Bonnet S, Pflieger A, Bourassa S, Tremblay E, Nehme B, Droit A, Bonnet S, et al. Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension. J Mol Med (Berl). 2015;93(5):573\u201384.","journal-title":"J Mol Med (Berl)"},{"key":"8419_CR69","doi-asserted-by":"crossref","unstructured":"Hemnes AR, Luther JM, Rhodes CJ, Burgess JP, Carlson J, Fan R, Fessel JP, Fortune N, Gerszten RE, Halliday SJ, et al. Human PAH is characterized by a pattern of lipid-related insulin resistance. JCI Insight. 2019;4(1).","DOI":"10.1172\/jci.insight.123611"},{"issue":"9","key":"8419_CR70","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1172\/JCI120847","volume":"128","author":"MK Culley","year":"2018","unstructured":"Culley MK, Chan SY. Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains. J Clin Invest. 2018;128(9):3704\u201315.","journal-title":"J Clin Invest"},{"issue":"6698","key":"8419_CR71","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/25931","volume":"395","author":"RT Nolte","year":"1998","unstructured":"Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature. 1998;395(6698):137\u201343.","journal-title":"Nature"},{"key":"8419_CR72","doi-asserted-by":"publisher","first-page":"816856","DOI":"10.1155\/2015\/816856","volume":"2015","author":"AJ Kroker","year":"2015","unstructured":"Kroker AJ, Bruning JB. Review of the Structural and Dynamic Mechanisms of PPARgamma Partial Agonism. Ppar Res. 2015;2015:816856.","journal-title":"Ppar Res"},{"issue":"1","key":"8419_CR73","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.str.2011.10.018","volume":"20","author":"TS Hughes","year":"2012","unstructured":"Hughes TS, Chalmers MJ, Novick S, Kuruvilla DS, Chang MR, Kamenecka TM, Rance M, Johnson BA, Burris TP, Griffin PR, et al. Ligand and receptor dynamics contribute to the mechanism of graded PPARgamma agonism. Structure. 2012;20(1):139\u201350.","journal-title":"Structure"},{"issue":"1","key":"8419_CR74","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41467-020-14750-x","volume":"11","author":"J Shang","year":"2020","unstructured":"Shang J, Mosure SA, Zheng J, Brust R, Bass J, Nichols A, Solt LA, Griffin PR, Kojetin DJ. A molecular switch regulating transcriptional repression and activation of PPARgamma. Nat Commun. 2020;11(1):956.","journal-title":"Nat Commun"},{"issue":"1","key":"8419_CR75","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1038\/s41467-018-07133-w","volume":"9","author":"R Brust","year":"2018","unstructured":"Brust R, Shang J, Fuhrmann J, Mosure SA, Bass J, Cano A, Heidari Z, Chrisman IM, Nemetchek MD, Blayo AL, et al. A structural mechanism for directing corepressor-selective inverse agonism of PPARgamma. Nat Commun. 2018;9(1):4687.","journal-title":"Nat Commun"},{"issue":"7","key":"8419_CR76","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nsmb.1855","volume":"17","author":"A le Maire","year":"2010","unstructured":"le Maire A, Teyssier C, Erb C, Grimaldi M, Alvarez S, de Lera AR, Balaguer P, Gronemeyer H, Royer CA, Germain P, et al. A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor. Nat Struct Mol Biol. 2010;17(7):801\u20137.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"8419_CR77","doi-asserted-by":"publisher","first-page":"17374","DOI":"10.1038\/s41598-018-35783-9","volume":"8","author":"M Noguchi","year":"2018","unstructured":"Noguchi M, Nomura A, Doi S, Yamaguchi K, Hirata K, Shiozaki M, Maeda K, Hirashima S, Kotoku M, Yamaguchi T, et al. Ternary crystal structure of human RORgamma ligand-binding-domain, an inhibitor and corepressor peptide provides a new insight into corepressor interaction. Sci Rep. 2018;8(1):17374.","journal-title":"Sci Rep"},{"issue":"6873","key":"8419_CR78","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/415813a","volume":"415","author":"HE Xu","year":"2002","unstructured":"Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, Mckee DD, Galardi CM, Plunket KD, Nolte RT, et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature. 2002;415(6873):813\u20137.","journal-title":"Nature"},{"key":"8419_CR79","doi-asserted-by":"publisher","first-page":"108391","DOI":"10.1016\/j.pharmthera.2023.108391","volume":"245","author":"H Chen","year":"2023","unstructured":"Chen H, Tan H, Wan J, Zeng Y, Wang J, Wang H, Lu X. PPAR-gamma signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets. Pharmacol Ther. 2023;245:108391.","journal-title":"Pharmacol Ther"},{"issue":"18","key":"8419_CR80","doi-asserted-by":"publisher","first-page":"E1193","DOI":"10.1097\/BRS.0b013e3182053f58","volume":"36","author":"YT Chen","year":"2011","unstructured":"Chen YT, Wei JD, Wang JP, Lee HH, Chiang ER, Lai HC, Chen LL, Lee YT, Tsai CC, Liu CL, et al. Isolation of mesenchymal stem cells from human ligamentum flavum: implicating etiology of ligamentum flavum hypertrophy. Spine (Phila Pa 1976). 2011;36(18):E1193\u2013200.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"7","key":"8419_CR81","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/BSD.0b013e3182a26532","volume":"27","author":"YM Kang","year":"2014","unstructured":"Kang YM, Suk KS, Lee BH, Kim HS, Lee KI, Park SY, Lee HM, Moon SH. Herniated intervertebral disk induces hypertrophy and ossification of ligamentum flavum. J Spinal Disord Tech. 2014;27(7):382\u20139.","journal-title":"J Spinal Disord Tech"},{"key":"8419_CR82","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.freeradbiomed.2023.03.014","volume":"201","author":"Y Tu","year":"2023","unstructured":"Tu Y, Liu J, Kong D, Guo X, Li J, Long Z, Peng J, Wang Z, Wu H, Liu P, et al. Irisin drives macrophage anti-inflammatory differentiation via JAK2-STAT6-dependent activation of PPARgamma and Nrf2 signaling. Free Radic Biol Med. 2023;201:98\u2013110.","journal-title":"Free Radic Biol Med"},{"issue":"13","key":"8419_CR83","doi-asserted-by":"publisher","first-page":"2100209","DOI":"10.1002\/advs.202100209","volume":"8","author":"X Wang","year":"2021","unstructured":"Wang X, Ji Y, Feng P, Liu R, Li G, Zheng J, Xue Y, Wei Y, Ji C, Chen D, et al. The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARgamma. Adv Sci (Weinh). 2021;8(13):2100209.","journal-title":"Adv Sci (Weinh)"},{"key":"8419_CR84","doi-asserted-by":"publisher","first-page":"119921","DOI":"10.1016\/j.lfs.2021.119921","volume":"284","author":"D Li","year":"2021","unstructured":"Li D, Rui YX, Guo SD, Luan F, Liu R, Zeng N. Ferulic acid: A review of its pharmacology, pharmacokinetics and derivatives. Life Sci. 2021;284:119921.","journal-title":"Life Sci"},{"issue":"6662","key":"8419_CR85","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/34178","volume":"391","author":"M Ricote","year":"1998","unstructured":"Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998;391(6662):79\u201382.","journal-title":"Nature"},{"issue":"12","key":"8419_CR86","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1074\/jbc.M310284200","volume":"279","author":"S Hazra","year":"2004","unstructured":"Hazra S, Xiong S, Wang J, Rippe RA, Krishna V, Chatterjee K, Tsukamoto H. Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem. 2004;279(12):11392\u2013401.","journal-title":"J Biol Chem"},{"issue":"1","key":"8419_CR87","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s10020-020-00173-3","volume":"26","author":"Q Lv","year":"2020","unstructured":"Lv Q, Wang J, Xu C, Huang X, Ruan Z, Dai Y. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt\/GSK-3beta\/beta-catenin and TGF-beta1\/Smad2\/3 signaling pathways. Mol Med. 2020;26(1):49.","journal-title":"Mol Med"},{"key":"8419_CR88","doi-asserted-by":"crossref","unstructured":"Landstrom M, Liu J. The 2019 FASEB Science Research Conference on the TGF-beta superfamily: signaling in development and disease, July 28 to August 2, 2019, West Palm Beach, Florida, USA. FASEB J. 2019; 33(12):13064\u201313067.","DOI":"10.1096\/fj.201902632"},{"issue":"6","key":"8419_CR89","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325\u201338.","journal-title":"Nat Rev Nephrol"},{"key":"8419_CR90","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.immunol.16.1.137","volume":"16","author":"JJ Letterio","year":"1998","unstructured":"Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol. 1998;16:137\u201361.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"8419_CR91","doi-asserted-by":"publisher","first-page":"e2003721","DOI":"10.1002\/advs.202003721","volume":"8","author":"X Wu","year":"2021","unstructured":"Wu X, Shu L, Zhang Z, Li J, Zong J, Cheong LY, Ye D, Lam K, Song E, Wang C, et al. Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells. Adv Sci (Weinh). 2021;8(11):e2003721.","journal-title":"Adv Sci (Weinh)"},{"key":"8419_CR92","doi-asserted-by":"publisher","first-page":"110618","DOI":"10.1016\/j.biopha.2020.110618","volume":"130","author":"Z Shen","year":"2020","unstructured":"Shen Z, Shen A, Chen X, Wu X, Chu J, Cheng Y, Peng M, Chen Y, Weygant N, Wu M, et al. Huoxin pill attenuates myocardial infarction-induced apoptosis and fibrosis via suppression of p53 and TGF-beta1\/Smad2\/3 pathways. Biomed Pharmacother. 2020;130:110618.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"8419_CR93","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2009.08.022","volume":"290","author":"E Lee","year":"2010","unstructured":"Lee E, Yi JY, Chung E, Son Y. Transforming growth factorbeta(1) transactivates EGFR via an H(2)O(2)-dependent mechanism in squamous carcinoma cell line. Cancer Lett. 2010;290(1):43\u20138.","journal-title":"Cancer Lett"},{"issue":"5","key":"8419_CR94","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/sj.onc.1210649","volume":"27","author":"CK Joo","year":"2008","unstructured":"Joo CK, Kim HS, Park JY, Seomun Y, Son MJ, Kim JT. Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-beta involves multiple signaling pathways. Oncogene. 2008;27(5):614\u201328.","journal-title":"Oncogene"},{"issue":"9","key":"8419_CR95","doi-asserted-by":"publisher","first-page":"21911","DOI":"10.3390\/ijms160921911","volume":"16","author":"Y Mao","year":"2015","unstructured":"Mao Y, Zhang S, Yu F, Li H, Guo C, Fan X. Ghrelin Attenuates Liver Fibrosis through Regulation of TGF-beta1 Expression and Autophagy. Int J Mol Sci. 2015;16(9):21911\u201330.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"8419_CR96","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1369\/0022155415627681","volume":"64","author":"F Xu","year":"2016","unstructured":"Xu F, Liu C, Zhou D, Zhang L. TGF-beta\/SMAD Pathway and Its Regulation in Hepatic Fibrosis. J Histochem Cytochem. 2016;64(3):157\u201367.","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"8419_CR97","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1007\/s10528-024-10811-8","volume":"63","author":"H Zhang","year":"2025","unstructured":"Zhang H, Hong Z, Jiang Z, Hu W, Hu J, Zhu R. miR-29b-3p Affects the Hypertrophy of Ligamentum Flavum in Lumbar Spinal Stenosis and its Mechanism. Biochem Genet. 2025;63(2):1824\u201338.","journal-title":"Biochem Genet"},{"issue":"3","key":"8419_CR98","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/jcmm.16267","volume":"25","author":"Q Yu","year":"2021","unstructured":"Yu Q, Cheng P, Wu J, Guo C. PPARgamma\/NF-kappaB and TGF-beta1\/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis. J Cell Mol Med. 2021;25(3):1645\u201360.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"8419_CR99","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jcp.26839","volume":"234","author":"L Liu","year":"2018","unstructured":"Liu L, Pan Y, Zhai C, Zhu Y, Ke R, Shi W, Wang J, Yan X, Su X, Song Y, et al. Activation of peroxisome proliferation-activated receptor-gamma inhibits transforming growth factor-beta1-induced airway smooth muscle cell proliferation by suppressing Smad-miR-21 signaling. J Cell Physiol. 2018;234(1):669\u201381.","journal-title":"J Cell Physiol"},{"issue":"10","key":"8419_CR100","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2174\/0113892002257928231031113337","volume":"24","author":"W Chen","year":"2023","unstructured":"Chen W, Su J, Liu Y, Gao T, Ji X, Li H, Li H, Wang Y, Zhang H, Lv S. Crocin Ameliorates Diabetic Nephropathy through Regulating Metabolism, CYP4A11\/PPARgamma, and TGF-beta\/Smad Pathways in Mice. Curr Drug Metab. 2023;24(10):709\u201322.","journal-title":"Curr Drug Metab"},{"key":"8419_CR101","doi-asserted-by":"crossref","unstructured":"Hata A, Chen YG. TGF-beta signaling from receptors to SMADs. Cold Spring Harb Perspect Biol. 2016;8(9).","DOI":"10.1101\/cshperspect.a022061"},{"issue":"9","key":"8419_CR102","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1096\/fj.08-128736","volume":"23","author":"AK Ghosh","year":"2009","unstructured":"Ghosh AK, Bhattacharyya S, Wei J, Kim S, Barak Y, Mori Y, Varga J. Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator. Faseb J. 2009;23(9):2968\u201377.","journal-title":"Faseb J"},{"issue":"4","key":"8419_CR103","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/art.20104","volume":"50","author":"AK Ghosh","year":"2004","unstructured":"Ghosh AK, Bhattacharyya S, Lakos G, Chen SJ, Mori Y, Varga J. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Arthritis Rheum. 2004;50(4):1305\u201318.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8419_CR104","doi-asserted-by":"publisher","first-page":"L1146","DOI":"10.1152\/ajplung.00383.2004","volume":"288","author":"HA Burgess","year":"2005","unstructured":"Burgess HA, Daugherty LE, Thatcher TH, Lakatos HF, Ray DM, Redonnet M, Phipps RP, Sime PJ. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol. 2005;288(6):L1146\u201353.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"8419_CR105","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00428-005-1264-9","volume":"446","author":"X Dolcet","year":"2005","unstructured":"Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Arch. 2005;446(5):475\u201382.","journal-title":"Virchows Arch"},{"key":"8419_CR106","doi-asserted-by":"publisher","first-page":"115309","DOI":"10.1016\/j.biopha.2023.115309","volume":"166","author":"MM Saber","year":"2023","unstructured":"Saber MM, Mahmoud MM, Amin HM, Essam RM. Therapeutic effects of combining curcumin and swimming in osteoarthritis using a rat model. Biomed Pharmacother. 2023;166:115309.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"8419_CR107","doi-asserted-by":"publisher","first-page":"E174","DOI":"10.1152\/ajpendo.90632.2008","volume":"297","author":"AH Remels","year":"2009","unstructured":"Remels AH, Langen RC, Gosker HR, Russell AP, Spaapen F, Voncken JW, Schrauwen P, Schols AM. PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle. Am J Physiol Endocrinol Metab. 2009;297(1):E174\u201383.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"8419_CR108","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10753-009-9125-3","volume":"32","author":"Y Yao","year":"2009","unstructured":"Yao Y, Xie M, Xue J, Zhang K. Aspirin inhibits MMP-2 and MMP-9 expression and activity through PPARalpha\/gamma and TIMP-1-mediated mechanisms in cultured mouse celiac macrophages. Inflammation. 2009;32(4):233\u201341.","journal-title":"Inflammation"},{"key":"8419_CR109","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.taap.2019.01.011","volume":"366","author":"G Li","year":"2019","unstructured":"Li G, Jin F, Du J, He Q, Yang B, Luo P. Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis. Toxicol Appl Pharmacol. 2019;366:10\u20136.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"82","key":"8419_CR110","doi-asserted-by":"publisher","first-page":"d8945","DOI":"10.1126\/sciimmunol.add8945","volume":"8","author":"T Fabre","year":"2023","unstructured":"Fabre T, Barron A, Christensen SM, Asano S, Bound K, Lech MP, Wadsworth MN, Chen X, Wang C, Wang J, et al. Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation. Sci Immunol. 2023;8(82):d8945.","journal-title":"Sci Immunol"},{"issue":"3","key":"8419_CR111","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"A Cuadrado","year":"2010","unstructured":"Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J. 2010;429(3):403\u201317.","journal-title":"Biochem J"},{"issue":"8","key":"8419_CR112","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","volume":"1773","author":"A Cuenda","year":"2007","unstructured":"Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta. 2007;1773(8):1358\u201375.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"8419_CR113","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.coph.2008.01.002","volume":"8","author":"R Bassi","year":"2008","unstructured":"Bassi R, Heads R, Marber MS, Clark JE. Targeting p38-MAPK in the ischaemic heart: kill or cure? Curr Opin Pharmacol. 2008;8(2):141\u20136.","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"8419_CR114","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0014-4886(03)00268-1","volume":"183","author":"GV Johnson","year":"2003","unstructured":"Johnson GV, Bailey CD. The p38 MAP kinase signaling pathway in Alzheimer\u2019s disease. Exp Neurol. 2003;183(2):263\u20138.","journal-title":"Exp Neurol"},{"issue":"9","key":"8419_CR115","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrd1177","volume":"2","author":"S Kumar","year":"2003","unstructured":"Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov. 2003;2(9):717\u201326.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"8419_CR116","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tibs.2007.06.007","volume":"32","author":"J Han","year":"2007","unstructured":"Han J, Sun P. The pathways to tumor suppression via route p38. Trends Biochem Sci. 2007;32(8):364\u201371.","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"8419_CR117","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/03008207.2012.754886","volume":"54","author":"X Cheng","year":"2013","unstructured":"Cheng X, Ni B, Zhang Z, Liu Q, Wang L, Ding Y, Hu Y. Polyol pathway mediates enhanced degradation of extracellular matrix via p38 MAPK activation in intervertebral disc of diabetic rats. Connect Tissue Res. 2013;54(2):118\u201322.","journal-title":"Connect Tissue Res"},{"issue":"3","key":"8419_CR118","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00774-018-0953-9","volume":"37","author":"L Qi","year":"2019","unstructured":"Qi L, Wang R, Shi Q, Yuan M, Jin M, Li D. Umbilical cord mesenchymal stem cell conditioned medium restored the expression of collagen II and aggrecan in nucleus pulposus mesenchymal stem cells exposed to high glucose. J Bone Min Metab. 2019;37(3):455\u201366.","journal-title":"J Bone Min Metab"},{"issue":"11","key":"8419_CR119","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00011-010-0203-7","volume":"59","author":"H Ji","year":"2010","unstructured":"Ji H, Wang H, Zhang F, Li X, Xiang L, Aiguo S. PPARgamma agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways. Inflamm Res. 2010;59(11):921\u20139.","journal-title":"Inflamm Res"},{"issue":"6","key":"8419_CR120","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/1440-1681.12918","volume":"45","author":"J Li","year":"2018","unstructured":"Li J, Xu B, Chen Z, Zhou C, Liao L, Qin Y, Yang C, Zhang X, Hu Z, Sun L, et al. PI3K\/AKT\/JNK\/p38 signalling pathway-mediated neural apoptosis in the prefrontal cortex of mice is involved in the antidepressant-like effect of pioglitazone. Clin Exp Pharmacol Physiol. 2018;45(6):525\u201335.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"8419_CR121","doi-asserted-by":"publisher","first-page":"6187695","DOI":"10.1155\/2021\/6187695","volume":"2021","author":"Y Han","year":"2021","unstructured":"Han Y, Wang J, Jin M, Jia L, Yan C, Wang Y. Shentong Zhuyu Decoction Inhibits Inflammatory Response, Migration, and Invasion and Promotes Apoptosis of Rheumatoid Arthritis Fibroblast-like Synoviocytes via the MAPK p38\/PPARgamma\/CTGF Pathway. Biomed Res Int. 2021;2021:6187695.","journal-title":"Biomed Res Int"},{"key":"8419_CR122","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biochi.2023.03.001","volume":"211","author":"Q Ma","year":"2023","unstructured":"Ma Q, Yu J, Zhang X, Wu X, Deng G. Wnt\/beta-catenin signaling pathway-a versatile player in apoptosis and autophagy. Biochimie. 2023;211:57\u201367.","journal-title":"Biochimie"},{"issue":"1","key":"8419_CR123","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G. Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"8419_CR124","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.yexcr.2017.07.025","volume":"359","author":"S Guan","year":"2017","unstructured":"Guan S, Zhou J. Frizzled-7 mediates TGF-beta-induced pulmonary fibrosis by transmitting non-canonical Wnt signaling. Exp Cell Res. 2017;359(1):226\u201334.","journal-title":"Exp Cell Res"},{"issue":"3","key":"8419_CR125","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/HEP.0000000000000569","volume":"79","author":"F Wang","year":"2024","unstructured":"Wang F, Chen L, Kong D, Zhang X, Xia S, Liang B, Li Y, Zhou Y, Zhang Z, Shao J, et al. Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A\/HIF-1alpha transcriptional complex. Hepatology. 2024;79(3):606\u201323.","journal-title":"Hepatology"},{"issue":"8","key":"8419_CR126","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/jcmm.13085","volume":"21","author":"L Xu","year":"2017","unstructured":"Xu L, Cui WH, Zhou WC, Li DL, Li LC, Zhao P, Mo XT, Zhang Z, Gao J. Activation of Wnt\/beta-catenin signalling is required for TGF-beta\/Smad2\/3 signalling during myofibroblast proliferation. J Cell Mol Med. 2017;21(8):1545\u201354.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"8419_CR127","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12967-022-03677-0","volume":"20","author":"Y Duan","year":"2022","unstructured":"Duan Y, Li J, Qiu S, Ni S, Cao Y. TCF7\/SNAI2\/miR-4306 feedback loop promotes hypertrophy of ligamentum flavum. J Transl Med. 2022;20(1):468.","journal-title":"J Transl Med"},{"issue":"12","key":"8419_CR128","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2174\/1871520620666201001104928","volume":"21","author":"Z Bai","year":"2021","unstructured":"Bai Z, Wu Y, Yan Y, Bai S, Kang H, Ma W, Zhang J, Gao Y, Hui B, Ma H, et al. Downregulation of GPR4 and TCF7 Promotes Apoptosis and Inhibits Growth and Invasion of Ovarian Cancer Cells. Anticancer Agents Med Chem. 2021;21(12):1544\u201350.","journal-title":"Anticancer Agents Med Chem"},{"key":"8419_CR129","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3389\/fimmu.2018.00745","volume":"9","author":"A Vallee","year":"2018","unstructured":"Vallee A, Lecarpentier Y. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT\/beta-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis. Front Immunol. 2018;9:745.","journal-title":"Front Immunol"},{"key":"8419_CR130","doi-asserted-by":"crossref","unstructured":"Vallee A, Lecarpentier Y, Vallee JN. Thermodynamic aspects and reprogramming cellular energy metabolism during the fibrosis process. Int J Mol Sci. 2017;18(12).","DOI":"10.3390\/ijms18122537"},{"key":"8419_CR131","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cellsig.2018.09.002","volume":"52","author":"AA Vander","year":"2018","unstructured":"Vander AA, Cao J, Li X. TGF-beta receptors: In and beyond TGF-beta signaling. Cell Signal. 2018;52:112\u201320.","journal-title":"Cell Signal"},{"issue":"2","key":"8419_CR132","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1053\/j.gastro.2009.10.002","volume":"138","author":"J Mann","year":"2010","unstructured":"Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology. 2010;138(2):705\u201314.","journal-title":"Gastroenterology"},{"issue":"Pt 3","key":"8419_CR133","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj20030426","volume":"376","author":"M Moldes","year":"2003","unstructured":"Moldes M, Zuo Y, Morrison RF, Silva D, Park BH, Liu J, Farmer SR. Peroxisome-proliferator-activated receptor gamma suppresses Wnt\/beta-catenin signalling during adipogenesis. Biochem J. 2003;376(Pt 3):607\u201313.","journal-title":"Biochem J"},{"issue":"30","key":"8419_CR134","doi-asserted-by":"publisher","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","volume":"272","author":"L Fajas","year":"1997","unstructured":"Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem. 1997;272(30):18779\u201389.","journal-title":"J Biol Chem"},{"issue":"3","key":"8419_CR135","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00125-009-1615-1","volume":"53","author":"B Gustafson","year":"2010","unstructured":"Gustafson B, Eliasson B, Smith U. Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis. Diabetologia. 2010;53(3):536\u201340.","journal-title":"Diabetologia"},{"issue":"2","key":"8419_CR136","doi-asserted-by":"publisher","first-page":"e171093","DOI":"10.1371\/journal.pone.0171093","volume":"12","author":"J Di Gregorio","year":"2017","unstructured":"Di Gregorio J, Sferra R, Speca S, Vetuschi A, Dubuquoy C, Desreumaux P, Pompili S, Cristiano L, Gaudio E, Flati V, et al. Role of glycogen synthase kinase-3beta and PPAR-gamma on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis. PLoS ONE. 2017;12(2):e171093.","journal-title":"PLoS ONE"},{"issue":"52","key":"8419_CR137","doi-asserted-by":"publisher","first-page":"90579","DOI":"10.18632\/oncotarget.21234","volume":"8","author":"A Vallee","year":"2017","unstructured":"Vallee A, Lecarpentier Y, Guillevin R, Vallee JN. Interactions between TGF-beta1, canonical WNT\/beta-catenin pathway and PPAR gamma in radiation-induced fibrosis. Oncotarget. 2017;8(52):90579\u2013604.","journal-title":"Oncotarget"},{"issue":"4","key":"8419_CR138","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1159\/000487574","volume":"45","author":"T Zhou","year":"2018","unstructured":"Zhou T, Du L, Chen C, Han C, Li X, Qin A, Zhao C, Zhang K, Zhao J. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1\/Akt Pathway. Cell Physiol Biochem. 2018;45(4):1472\u201386.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"8419_CR139","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1172\/JCI9652","volume":"106","author":"Y Kawahito","year":"2000","unstructured":"Kawahito Y, Kondo M, Tsubouchi Y, Hashiramoto A, Bishop-Bailey D, Inoue K, Kohno M, Yamada R, Hla T, Sano H. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest. 2000;106(2):189\u201397.","journal-title":"J Clin Invest"},{"issue":"9","key":"8419_CR140","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1191\/0961203305lu2223oa","volume":"14","author":"A Consoli","year":"2005","unstructured":"Consoli A, Devangelio E. Thiazolidinediones and inflammation. Lupus. 2005;14(9):794\u20137.","journal-title":"Lupus"},{"issue":"8","key":"8419_CR141","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1038\/s41401-021-00833-y","volume":"43","author":"ZY Xie","year":"2022","unstructured":"Xie ZY, Dong W, Zhang L, Wang MJ, Xiao ZM, Zhang YH, Shi WX, Huang Y, Yang Y, Li CL, et al. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury. Acta Pharmacol Sin. 2022;43(8):2081\u201393.","journal-title":"Acta Pharmacol Sin"},{"key":"8419_CR142","doi-asserted-by":"crossref","unstructured":"Eguchi A, Coleman R, Gresham K, Gao E, Ibetti J, Chuprun JK, Koch WJ. GRK5 is a regulator of fibroblast activation and cardiac fibrosis. Proc Natl Acad Sci USA. 2021;118(5).","DOI":"10.1073\/pnas.2012854118"},{"issue":"1","key":"8419_CR143","doi-asserted-by":"publisher","first-page":"e85542","DOI":"10.1371\/journal.pone.0085542","volume":"9","author":"T Nakamura","year":"2014","unstructured":"Nakamura T, Okada T, Endo M, Kadomatsu T, Taniwaki T, Sei A, Odagiri H, Masuda T, Fujimoto T, Nakamura T, et al. Angiopoietin-like protein 2 induced by mechanical stress accelerates degeneration and hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis. PLoS ONE. 2014;9(1):e85542.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"8419_CR144","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11010-008-9848-8","volume":"317","author":"Y Bao","year":"2008","unstructured":"Bao Y, Li R, Jiang J, Cai B, Gao J, Le K, Zhang F, Chen S, Liu P. Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin\/NFAT signaling pathway. Mol Cell Biochem. 2008;317(1\u20132):189\u201396.","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"8419_CR145","doi-asserted-by":"publisher","first-page":"e21951","DOI":"10.1096\/fj.202100947R","volume":"35","author":"M Du","year":"2021","unstructured":"Du M, Yang L, Liu B, Yang L, Mao X, Liang M, Huang K. Inhibition of NFAT suppresses foam cell formation and the development of diet-induced atherosclerosis. Faseb J. 2021;35(10):e21951.","journal-title":"Faseb J"},{"issue":"1","key":"8419_CR146","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1086\/689749","volume":"7","author":"A Chaudhry","year":"2017","unstructured":"Chaudhry A, Carthan KA, Kang BY, Calvert J, Sutliff RL, Michael HC. PPARgamma attenuates hypoxia-induced hypertrophic transcriptional pathways in the heart. Pulm Circ. 2017;7(1):98\u2013107.","journal-title":"Pulm Circ"},{"issue":"6","key":"8419_CR147","doi-asserted-by":"publisher","first-page":"8315","DOI":"10.3892\/mmr.2017.7673","volume":"16","author":"J Yao","year":"2017","unstructured":"Yao J, Lu Y, Zhi M, Hu P, Wu W, Gao X. Dietary n\u20133 polyunsaturated fatty acids ameliorate Crohn\u2019s disease in rats by modulating the expression of PPAR\u2013gamma\/NFAT. Mol Med Rep. 2017;16(6):8315\u201322.","journal-title":"Mol Med Rep"},{"issue":"1","key":"8419_CR148","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1038\/s41598-017-08411-1","volume":"7","author":"V Reyhani","year":"2017","unstructured":"Reyhani V, Tsioumpekou M, van Wieringen T, Rask L, Lennartsson J, Rubin K. PDGF-BB enhances collagen gel contraction through a PI3K-PLCgamma-PKC-cofilin pathway. Sci Rep. 2017;7(1):8924.","journal-title":"Sci Rep"},{"issue":"7","key":"8419_CR149","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1172\/JCI41203","volume":"120","author":"S Cao","year":"2010","unstructured":"Cao S, Yaqoob U, Das A, Shergill U, Jagavelu K, Huebert RC, Routray C, Abdelmoneim S, Vasdev M, Leof E, et al. Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF\/TGF-beta signaling in hepatic stellate cells. J Clin Invest. 2010;120(7):2379\u201394.","journal-title":"J Clin Invest"},{"key":"8419_CR150","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mam.2017.11.008","volume":"62","author":"BM Klinkhammer","year":"2018","unstructured":"Klinkhammer BM, Floege J, Boor P. PDGF in organ fibrosis. Mol Aspects Med. 2018;62:44\u201362.","journal-title":"Mol Aspects Med"},{"issue":"8","key":"8419_CR151","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.jid.2017.03.032","volume":"137","author":"K Makino","year":"2017","unstructured":"Makino K, Makino T, Stawski L, Mantero JC, Lafyatis R, Simms R, Trojanowska M. Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis. J Invest Dermatol. 2017;137(8):1671\u201381.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"8419_CR152","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1124\/jpet.112.194357","volume":"342","author":"ZM Hao","year":"2012","unstructured":"Hao ZM, Fan XB, Li S, Lv YF, Su HQ, Jiang HP, Li HH. Vaccination with platelet-derived growth factor B kinoids inhibits CCl(4)-induced hepatic fibrosis in mice. J Pharmacol Exp Ther. 2012;342(3):835\u201342.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"8419_CR153","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/BF02934089","volume":"32","author":"Y Ikura","year":"1997","unstructured":"Ikura Y, Morimoto H, Ogami M, Jomura H, Ikeoka N, Sakurai M. Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease. J Gastroenterol. 1997;32(4):496\u2013501.","journal-title":"J Gastroenterol"},{"issue":"4","key":"8419_CR154","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/wrr.12444","volume":"24","author":"RJ Snyder","year":"2016","unstructured":"Snyder RJ, Lantis J, Kirsner RS, Shah V, Molyneaux M, Carter MJ, Macrophages. A review of their role in wound healing and their therapeutic use. Wound Repair Regen. 2016;24(4):613\u201329.","journal-title":"Wound Repair Regen"},{"issue":"6342","key":"8419_CR155","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1126\/science.aam7928","volume":"356","author":"SA Eming","year":"2017","unstructured":"Eming SA, Wynn TA, Martin P. Inflammation and metabolism in tissue repair and regeneration. Science. 2017;356(6342):1026\u201330.","journal-title":"Science"},{"issue":"1","key":"8419_CR156","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","volume":"295","author":"E Buchdunger","year":"2000","unstructured":"Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ, Lydon NB. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther. 2000;295(1):139\u201345.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"8419_CR157","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1084\/jem.20041393","volume":"201","author":"A Abdollahi","year":"2005","unstructured":"Abdollahi A, Li M, Ping G, Plathow C, Domhan S, Kiessling F, Lee LB, Mcmahon G, Grone HJ, Lipson KE, et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med. 2005;201(6):925\u201335.","journal-title":"J Exp Med"},{"issue":"11","key":"8419_CR158","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1164\/rccm.200404-531OC","volume":"171","author":"Y Aono","year":"2005","unstructured":"Aono Y, Nishioka Y, Inayama M, Ugai M, Kishi J, Uehara H, Izumi K, Sone S. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med. 2005;171(11):1279\u201385.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"8419_CR159","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1164\/rccm.200505-717OC","volume":"173","author":"NI Chaudhary","year":"2006","unstructured":"Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med. 2006;173(7):769\u201376.","journal-title":"Am J Respir Crit Care Med"},{"key":"8419_CR160","doi-asserted-by":"crossref","unstructured":"Zhang L, Zhang H, Gu J, Xu W, Yuan N, Sun J, Li H. Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPAR-\u03b3 in carbon tetrachloride-treated mice. Int Immunopharmacol. 2022;113(Pt B):109433.","DOI":"10.1016\/j.intimp.2022.109433"},{"issue":"7","key":"8419_CR161","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/jcmm.12286","volume":"18","author":"F Zhang","year":"2014","unstructured":"Zhang F, Zhang Z, Chen L, Kong D, Zhang X, Lu C, Lu Y, Zheng S. Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. J Cell Mol Med. 2014;18(7):1392\u2013406.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"8419_CR162","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1139\/o03-069","volume":"81","author":"A Leask","year":"2003","unstructured":"Leask A, Abraham DJ. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol. 2003;81(6):355\u201363.","journal-title":"Biochem Cell Biol"},{"key":"8419_CR163","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fonc.2019.01399","volume":"9","author":"D Aguilar-Cazares","year":"2019","unstructured":"Aguilar-Cazares D, Chavez-Dominguez R, Carlos-Reyes A, Lopez-Camarillo C, Hernadez DLCO, Lopez-Gonzalez JS. Contribution of Angiogenesis to Inflammation and Cancer. Front Oncol. 2019;9:1399.","journal-title":"Front Oncol"},{"issue":"1","key":"8419_CR164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10456-017-9583-4","volume":"21","author":"S Sajib","year":"2018","unstructured":"Sajib S, Zahra FT, Lionakis MS, German NA, Mikelis CM. Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions. Angiogenesis. 2018;21(1):1\u201314.","journal-title":"Angiogenesis"},{"issue":"4","key":"8419_CR165","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1136\/jim-2015-000024","volume":"64","author":"N Jirathanathornnukul","year":"2016","unstructured":"Jirathanathornnukul N, Limthongkul W, Yingsakmongkol W, Singhatanadgige W, Parkpian V, Honsawek S. Increased expression of vascular endothelial growth factor is associated with hypertrophic ligamentum flavum in lumbar spinal canal stenosis. J Invest medicine: official publication Am Federation Clin Res. 2016;64(4):882\u20137.","journal-title":"J Invest medicine: official publication Am Federation Clin Res"},{"issue":"2","key":"8419_CR166","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1227\/NEU.0000000000000755","volume":"77","author":"JW Hur","year":"2015","unstructured":"Hur JW, Kim BJ, Park JH, Kim JH, Park YK, Kwon TH, Moon HJ. The Mechanism of Ligamentum Flavum Hypertrophy: Introducing Angiogenesis as a Critical Link That Couples Mechanical Stress and Hypertrophy. Neurosurgery. 2015;77(2):274\u201381.","journal-title":"Neurosurgery"},{"issue":"8","key":"8419_CR167","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s00586-017-4981-2","volume":"26","author":"JW Hur","year":"2017","unstructured":"Hur JW, Bae T, Ye S, Kim JH, Lee S, Kim K, Lee SH, Kim JS, Lee JB, Cho TH, et al. Myofibroblast in the ligamentum flavum hypertrophic activity. Eur Spine J. 2017;26(8):2021\u201330.","journal-title":"Eur Spine J"},{"issue":"3","key":"8419_CR168","doi-asserted-by":"publisher","first-page":"E147","DOI":"10.1097\/BRS.0b013e3182269b19","volume":"37","author":"HJ Moon","year":"2012","unstructured":"Moon HJ, Park YK, Ryu Y, Kim JH, Kwon TH, Chung HS, Kim JH. The angiogenic capacity from ligamentum flavum subsequent to inflammation: a critical component of the pathomechanism of hypertrophy. Spine (Phila Pa 1976). 2012;37(3):E147\u201355.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5","key":"8419_CR169","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/S0006-291X(02)00385-6","volume":"293","author":"S Goetze","year":"2002","unstructured":"Goetze S, Eilers F, Bungenstock A, Kintscher U, Stawowy P, Blaschke F, Graf K, Law RE, Fleck E, Grafe M. PPAR activators inhibit endothelial cell migration by targeting Akt. Biochem Biophys Res Commun. 2002;293(5):1431\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"8419_CR170","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/01.HYP.0000035522.63647.D3","volume":"40","author":"S Goetze","year":"2002","unstructured":"Goetze S, Bungenstock A, Czupalla C, Eilers F, Stawowy P, Kintscher U, Spencer-Hansch C, Graf K, Nurnberg B, Law RE, et al. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands. Hypertension. 2002;40(5):748\u201354.","journal-title":"Hypertension"},{"issue":"3","key":"8419_CR171","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/01.ATV.19.3.546","volume":"19","author":"N Marx","year":"1999","unstructured":"Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J. PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol. 1999;19(3):546\u201351.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"8419_CR172","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1172\/JCI0215634","volume":"110","author":"D Panigrahy","year":"2002","unstructured":"Panigrahy D, Singer S, Shen LQ, Butterfield CE, Freedman DA, Chen EJ, Moses MA, Kilroy S, Duensing S, Fletcher C, et al. PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest. 2002;110(7):923\u201332.","journal-title":"J Clin Invest"},{"issue":"6","key":"8419_CR173","doi-asserted-by":"publisher","first-page":"359","DOI":"10.5483\/BMBRep.2011.44.6.359","volume":"44","author":"EY Park","year":"2011","unstructured":"Park EY, Woo YM, Park JH. Polycystic kidney disease and therapeutic approaches. Bmb Rep. 2011;44(6):359\u201368.","journal-title":"Bmb Rep"},{"issue":"4","key":"8419_CR174","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10456-008-9118-0","volume":"11","author":"A Aljada","year":"2008","unstructured":"Aljada A, O\u2019Connor L, Fu YY, Mousa SA. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis. Angiogenesis. 2008;11(4):361\u20137.","journal-title":"Angiogenesis"},{"issue":"16","key":"8419_CR175","doi-asserted-by":"publisher","first-page":"E1093","DOI":"10.1097\/BRS.0b013e318203e2b5","volume":"36","author":"N Altinkaya","year":"2011","unstructured":"Altinkaya N, Yildirim T, Demir S, Alkan O, Sarica FB. Factors associated with the thickness of the ligamentum flavum: is ligamentum flavum thickening due to hypertrophy or buckling? Spine (Phila Pa 1976). 2011;36(16):E1093\u20137.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"6","key":"8419_CR176","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00776-011-0135-2","volume":"16","author":"G Cui","year":"2011","unstructured":"Cui G, Watanabe K, Miyauchi Y, Hosogane N, Tsuji T, Ishii K, Nakamura M, Toyama Y, Chiba K, Miyamoto T, et al. Matrix metalloproteinase 13 in the ligamentum flavum from lumbar spinal canal stenosis patients with and without diabetes mellitus. J Orthop Sci. 2011;16(6):785\u201390.","journal-title":"J Orthop Sci"},{"issue":"5","key":"8419_CR177","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/CM9.0000000000000680","volume":"133","author":"QL Lu","year":"2020","unstructured":"Lu QL, Wang XZ, Xie W, Chen XW, Zhu YL, Li XG. Macrophage migration inhibitory factor may contribute to hypertrophy of lumbar ligamentum flavum in type 2 diabetes mellitus. Chin Med J (Engl). 2020;133(5):623\u20135.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"8419_CR178","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/BSD.0b013e31813707af","volume":"21","author":"R Lotan","year":"2008","unstructured":"Lotan R, Oron A, Anekstein Y, Shalmon E, Mirovsky Y. Lumbar stenosis and systemic diseases: is there any relevance? J Spinal Disord Tech. 2008;21(4):247\u201351.","journal-title":"J Spinal Disord Tech"},{"issue":"2","key":"8419_CR179","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.tem.2023.10.004","volume":"35","author":"LC Lin","year":"2024","unstructured":"Lin LC, Liu ZY, Yang JJ, Zhao JY, Tao H. Lipid metabolism reprogramming in cardiac fibrosis. Trends Endocrinol Metab. 2024;35(2):164\u201375.","journal-title":"Trends Endocrinol Metab"},{"key":"8419_CR180","doi-asserted-by":"publisher","first-page":"106361","DOI":"10.1016\/j.biocel.2022.106361","volume":"155","author":"Y Tian","year":"2023","unstructured":"Tian Y, Duan C, Feng J, Liao J, Yang Y, Sun W. Roles of lipid metabolism and its regulatory mechanism in idiopathic pulmonary fibrosis: A review. Int J Biochem Cell Biol. 2023;155:106361.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"8419_CR181","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","volume":"33","author":"P Trivedi","year":"2021","unstructured":"Trivedi P, Wang S, Friedman SL. The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells. Cell Metab. 2021;33(2):242\u201357.","journal-title":"Cell Metab"},{"issue":"2","key":"8419_CR182","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman SL, Pinzani M. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. Hepatology. 2022;75(2):473\u201388.","journal-title":"Hepatology"},{"issue":"5","key":"8419_CR183","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/s41418-023-01130-3","volume":"30","author":"Y Feng","year":"2023","unstructured":"Feng Y, Guo S, Zhao Y, Dong H, Qian J, Hu Y, Wu L, Jia Y, Zhao R. DNA 5mC and RNA m(6)A modification successively facilitates the initiation and perpetuation stages of HSC activation in liver fibrosis progression. Cell Death Differ. 2023;30(5):1211\u201320.","journal-title":"Cell Death Differ"},{"issue":"2","key":"8419_CR184","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/sj.cdd.4401979","volume":"14","author":"J Mann","year":"2007","unstructured":"Mann J, Oakley F, Akiboye F, Elsharkawy A, Thorne AW, Mann DA. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ. 2007;14(2):275\u201385.","journal-title":"Cell Death Differ"},{"issue":"7","key":"8419_CR185","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/bph.15655","volume":"179","author":"A Wei","year":"2022","unstructured":"Wei A, Gao Q, Chen F, Zhu X, Chen X, Zhang L, Su X, Dai J, Shi Y, Cao W. Inhibition of DNA methylation de-represses peroxisome proliferator-activated receptor-gamma and attenuates pulmonary fibrosis. Br J Pharmacol. 2022;179(7):1304\u201318.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"8419_CR186","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bcp.2014.07.018","volume":"92","author":"L Wang","year":"2014","unstructured":"Wang L, Waltenberger B, Pferschy-Wenzig EM, Blunder M, Liu X, Malainer C, Blazevic T, Schwaiger S, Rollinger JM, Heiss EH, et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARgamma): a review. Biochem Pharmacol. 2014;92(1):73\u201389.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"8419_CR187","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1523-1755.2005.00151.x","volume":"67","author":"H Li","year":"2005","unstructured":"Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF, Varghese Z. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int. 2005;67(3):867\u201374.","journal-title":"Kidney Int"},{"issue":"6","key":"8419_CR188","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/10408398.2018.1552244","volume":"60","author":"SS Patel","year":"2020","unstructured":"Patel SS, Acharya A, Ray RS, Agrawal R, Raghuwanshi R, Jain P. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Crit Rev Food Sci Nutr. 2020;60(6):887\u2013939.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"3","key":"8419_CR189","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jnutbio.2013.11.008","volume":"25","author":"S Periasamy","year":"2014","unstructured":"Periasamy S, Hsu DZ, Chang PC, Liu MY. Sesame oil attenuates nutritional fibrosing steatohepatitis by modulating matrix metalloproteinases-2, 9 and PPAR-gamma. J Nutr Biochem. 2014;25(3):337\u201344.","journal-title":"J Nutr Biochem"},{"key":"8419_CR190","doi-asserted-by":"crossref","unstructured":"Legchenko E, Chouvarine P, Borchert P, Fernandez-Gonzalez A, Snay E, Meier M, Maegel L, Mitsialis SA, Rog-Zielinska EA, Kourembanas S, et al. PPAR-\u03b3 agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation. Sci Transl Med. 2018;10(438).","DOI":"10.1126\/scitranslmed.aao0303"},{"key":"8419_CR191","doi-asserted-by":"publisher","first-page":"175841","DOI":"10.1016\/j.ejphar.2023.175841","volume":"953","author":"A Banik","year":"2023","unstructured":"Banik A, Datta CR, Vashishtha S, Gupta S, Kar A, Bandyopadhyay A, Kundu B, Sarkar S. Deoxyelephantopin-a novel PPARgamma agonist regresses pressure overload-induced cardiac fibrosis via IL-6\/STAT-3 pathway in crosstalk with PKCdelta. Eur J Pharmacol. 2023;953:175841.","journal-title":"Eur J Pharmacol"},{"key":"8419_CR192","doi-asserted-by":"crossref","unstructured":"Chen Z, Ghavimi S, Wu M, Mcnamara J, Barreiro O, Maridas D, Kratchmarov R, Siegel A, Djeddi S, Gutierrez-Arcelus M, et al. PPAR-\u03b3 agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFR\u03b1+ mesenchymal cells. JCI Insight. 2023;8(24).","DOI":"10.1172\/jci.insight.165324"},{"key":"8419_CR193","doi-asserted-by":"crossref","unstructured":"Yang HC, Fogo AB. Fibrosis and renal aging. Kidney Int Suppl (2011). 2014;4(1):75\u201378.","DOI":"10.1038\/kisup.2014.14"},{"key":"8419_CR194","doi-asserted-by":"publisher","first-page":"110812","DOI":"10.1016\/j.cellsig.2023.110812","volume":"110","author":"G Dong","year":"2023","unstructured":"Dong G, Huang X, Xu Y, Chen R, Chen S. Mechanical stress induced EndoMT in endothelial cells through PPARgamma downregulation. Cell Signal. 2023;110:110812.","journal-title":"Cell Signal"},{"issue":"12","key":"8419_CR195","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.tem.2010.08.006","volume":"21","author":"Y Wan","year":"2010","unstructured":"Wan Y. PPARgamma in bone homeostasis. Trends Endocrinol Metab. 2010;21(12):722\u20138.","journal-title":"Trends Endocrinol Metab"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08419-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08419-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08419-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:02:55Z","timestamp":1786147375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08419-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":195,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8419"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08419-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1014"}}